摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-phenyl-N-prop-2-enylmethanimine | 21064-27-7

中文名称
——
中文别名
——
英文名称
1-phenyl-N-prop-2-enylmethanimine
英文别名
N-(phenylmethylidene)-2-propene-1-amine;benzaldehyde N-allylamine
1-phenyl-N-prop-2-enylmethanimine化学式
CAS
21064-27-7;68003-55-4
化学式
C10H11N
mdl
——
分子量
145.204
InChiKey
GXFNRLVWKGAVGK-LUAWRHEFSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    96 °C(Press: 12 Torr)
  • 密度:
    0.86±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.29
  • 重原子数:
    11.0
  • 可旋转键数:
    3.0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.1
  • 拓扑面积:
    12.36
  • 氢给体数:
    0.0
  • 氢受体数:
    1.0

SDS

SDS:710642753ed6c82f1e71a34bd56b9ddf
查看

反应信息

  • 作为反应物:
    描述:
    (氯磺酰基)乙酸乙酯1-phenyl-N-prop-2-enylmethanimine四氢呋喃 为溶剂, 反应 24.0h, 以60%的产率得到ethyl trans-2-allyl-3-phenyl-1,2-thiazetidine-4-carbonxlate 1,1-dioxide
    参考文献:
    名称:
    Sulfa-Staudinger环加成中的取代基控制的环选择性和立体选择性
    摘要:
    在亚胺和磺酰氯的磺胺-施陶丁格环加成中,环选择性主要受磺酰氯的α-取代基的电子效应和亚胺的亲核性控制。具有弱给电子和吸电子取代基的磺酰氯更喜欢[2 s +2 i ]环,形成顺式和反式-β-杜鹃花的混合物。带有强吸电子α-取代基的磺酰氯根据亚胺的亲核性表现出不同的年环选择性,具体如下:(1)取代基比甲基大的弱亲核亚胺仅经历[2 s +2 i ]环化反应,生成反式-β-杜鹃花;(2)具有N-甲基取代基的强亲核亚胺通常同时发生[2 s +2 i ]和[2 s +2 i +2 i ]环化反应,从而传递反式-β-杜鹃花和rel(3 S,5 S由一分子的亚砜和两分子的亚胺组成的,6 R)-1,2,4-噻二嗪烷1,1-二氧化物; (3)更强的亲核环状(Z)-亚胺主要产生[2 s +2 i +2 i ]环,产生一对非对映异构体[2 s +2i +2 i ]年环过氧化物1,2,4-噻二嗪烷1,1-二氧化物。
    DOI:
    10.1021/acs.joc.5b00312
  • 作为产物:
    描述:
    苯甲醛丙烯胺 在 magnesium sulfate 作用下, 以 二氯甲烷 为溶剂, 反应 2.0h, 以100%的产率得到1-phenyl-N-prop-2-enylmethanimine
    参考文献:
    名称:
    Sulfa-Staudinger环加成中的取代基控制的环选择性和立体选择性
    摘要:
    在亚胺和磺酰氯的磺胺-施陶丁格环加成中,环选择性主要受磺酰氯的α-取代基的电子效应和亚胺的亲核性控制。具有弱给电子和吸电子取代基的磺酰氯更喜欢[2 s +2 i ]环,形成顺式和反式-β-杜鹃花的混合物。带有强吸电子α-取代基的磺酰氯根据亚胺的亲核性表现出不同的年环选择性,具体如下:(1)取代基比甲基大的弱亲核亚胺仅经历[2 s +2 i ]环化反应,生成反式-β-杜鹃花;(2)具有N-甲基取代基的强亲核亚胺通常同时发生[2 s +2 i ]和[2 s +2 i +2 i ]环化反应,从而传递反式-β-杜鹃花和rel(3 S,5 S由一分子的亚砜和两分子的亚胺组成的,6 R)-1,2,4-噻二嗪烷1,1-二氧化物; (3)更强的亲核环状(Z)-亚胺主要产生[2 s +2 i +2 i ]环,产生一对非对映异构体[2 s +2i +2 i ]年环过氧化物1,2,4-噻二嗪烷1,1-二氧化物。
    DOI:
    10.1021/acs.joc.5b00312
点击查看最新优质反应信息

文献信息

  • PREPARING METHOD OF SOLID CARBAMIC ACID DERIVATIVES
    申请人:Sogang University Research Foundation
    公开号:US20140051858A1
    公开(公告)日:2014-02-20
    The present disclosure relates to a preparation method for powder of a carbamic acid derivative, which includes reacting a liquid amine derivative with carbon dioxide at a temperature in a range of from about −30° C. to about 500° C. at a pressure in a range of from about 0.3 MPa to about 100 MPa. In addition, the present disclosure relates to a reduction method for powder of a carbamic acid derivative to a liquid amine derivative and carbon dioxide, which includes dissolving powder of the carbamic acid derivative prepared in a solvent; refluxing the carbamic acid derivative at a temperature in a range of from about 30° C. to about 100° C.; and evaporating the solvent. The preparation method for a carbamic acid derivative powder according to the present disclosure enables easy conversion into pure powder of solid carbamic acid derivative without by-products and can remarkably reduce time and energy required for solidification by reacting carbon dioxides and amines with carbon dioxides in high pressure conditions without the use of a solvent. In addition, the prepared solid compounds can be used as a liquid amine substitute or used in a carbamic acid derivative form as necessary.
    本公开涉及一种羰基酸衍生物粉末的制备方法,包括将液态胺衍生物二氧化碳在温度范围从约-30°C到约500°C的压力范围从约0.3兆帕到约100兆帕下反应。此外,本公开还涉及一种将羰基酸衍生物粉末还原为液态胺衍生物二氧化碳的方法,包括将制备的羰基酸衍生物粉末溶解在溶剂中;在温度范围从约30°C到约100°C下回流羰基酸衍生物;蒸发溶剂。根据本公开的羰基酸衍生物粉末的制备方法,可以在高压条件下通过将二氧化碳和胺与二氧化碳反应而无需使用溶剂,轻松将其转化为纯净的固态羰基酸衍生物粉末,而且可以显著减少固化所需的时间和能量,并且避免了副产物的产生。此外,制备的固体化合物可用作液态胺替代品,或根据需要以羰基酸衍生物形式使用。
  • N-(2-(2-amino-2-phenylethyl)phenyl)-2,2-dimethyl-propanamid and derivatives and a process for preparing the same
    申请人:HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED
    公开号:EP0066773B1
    公开(公告)日:1984-09-05
  • PREPARATION METHOD FOR SOLID POWDER OF A CARBAMIC ACID DERIVATIVE
    申请人:Sogang University Research Foundation
    公开号:US20150099886A1
    公开(公告)日:2015-04-09
    The present application relates to a preparation method for solid powder of a carbamic acid derivative, which includes reacting an amine derivative with carbon dioxide at a temperature in a range of from about −30° C. to about 500° C. and at a pressure in a range of from about 0.3 MPa to about 100 MPa. In addition, the present disclosure relates to a reduction method for solid powder of a carbamic acid derivative to an amine derivative and carbon dioxide, which includes dissolving solid powder of the carbamic acid derivative prepared in a solvent; refluxing the carbamic acid derivative at a temperature in a range of from about 30° C. to about 100° C.; and evaporating the solvent.
  • PREPARATION METHOD FOR AN IMINE COMPOUND AND REDUCTION METHOD FOR SOLID POWDER OF A CARBAMIC ACID DERIVATIVE
    申请人:Sogang University Research Foundation
    公开号:US20150344451A1
    公开(公告)日:2015-12-03
    The present application relates to a preparation method for solid powder of a carbamic acid derivative, which includes reacting an amine derivative with carbon dioxide at a temperature in a range of from about −30° C. to about 500° C. and at a pressure in a range of from about 0.3 MPa to about 100 MPa. In addition, the present disclosure relates to a reduction method for solid powder of a carbamic acid derivative to an amine derivative and carbon dioxide, which includes dissolving solid powder of the carbamic acid derivative prepared in a solvent; refluxing the carbamic acid derivative at a temperature in a range of from about 30° C. to about 100° C.; and evaporating the solvent.
  • US6087520A
    申请人:——
    公开号:US6087520A
    公开(公告)日:2000-07-11
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫